Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

A new study finds that oral ketamine significantly reduces PTSD symptoms, with 73% of participants seeing a 50% reduction in ...

Ketamine is a short-acting anesthetic that has been used for decades in medical settings. In recent years, researchers have ...

“Ketamine felt like a giant exhale ... and then what I had, which is an injection in the muscle, which puts you over the edge very quickly,” he told Yahoo Life in 2023. Baltierra explained ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

According to a new study, ketamine use has risen significantly since 2015. The results highlight the need for closer monitoring of recreational ketamine use. A recent study analyzing data from the ...

Start your Independent Premium subscription today. Ketamine was previously reclassified from class C to class B in 2014, and since then, the number of users has continued to rise. The most recent ...

Recreational ketamine use has local researchers sounding the alarm. Dr. Philip Botkiss is the medical director of the West Coast Ketamine Center. He says he's seen a good response from patients ...

The government is considering reclassifying ketamine as a Class A substance after a record number of people reported using the drug. Ketamine is currently a Class B substance, meaning the maximum ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...